Brain changes associated with Alzheimer’s disease may begin long before the amyloid plaques build up

01/11/2026

Amyloid-related abnormalities are widely considered the earliest pathological hallmark of Alzheimer’s disease and the first detectable biological manifestation of the disease itself. According to this, in the proposed temporal sequence of biomarker changes, alterations in brain structure are thought to happen following the accumulation of elevated amyloid-beta (Aβ) levels, which are regarded as the earliest detectable imaging marker of Alzheimer’s disease. However, whether structural brain changes may already occur in the years preceding the onset of Aβ positivity remains unknown. 

In a recent study published in Nature Neuroscience, a team of researchers led by Dr Roe J. M. and Prof Wang Y. (University of Oslo, Norway), investigated longitudinal brain changes in cognitively healthy individuals followed over nearly two decades. The study combined data from three cohorts (the Center for Lifespan Changes in Brain and Cognition, the Berkeley Aging Cohort Study, and the Alzheimer’s Disease Neuroimaging Initiative). In total, the researchers analysed 4,570 MRI scans from 1,051 individuals, which allowed them to examine brain structural changes over an extended period. The analyses focused on MRI scans acquired before individuals first became Aβ positive. Of the 1,051 individuals, 691 had available Aβ-PET scan data, comprising a total of 1,684 scans. Based on the PET scans, participants were classified into two groups; those who converted from Aβ-negative to Aβ-positive during follow-up and those who remained Aβ-negative across all available scans. The researchers then examined the longitudinal MRI data to compare trajectories on brain structural changes between individuals who subsequently developed detectable amyloid pathology and those who remained amyloid-negative. 

The researchers found that individuals who subsequently developed Aβ accumulation had a thicker cortex and exhibited less longitudinal cortical thinning compared with those who remained Aβ-negative. These structural changes were already detectable in MRI scans acquired at least seven years before individuals showed high levels of Aβ accumulation. These findings suggest that alterations in brain structure may precede the detection of amyloid pathology (i.e. plaque build-up) on PET scans by several years, challenging the idea that plaque accumulation is the earliest sign of Alzheimer’s disease. 

Although further research is needed to replicate and confirm these findings, they may have important implications for the development of Alzheimer’s disease treatments. If structural brain changes begin before detectable amyloid pathology, and through mechanisms that are, at least, partly independent of amyloid plaque accumulation, research should also explore treatment strategies targeting mechanisms and biological processes beyond amyloid plaque accumulation. 
https://www.nature.com/articles/s41593-026-02363-4